Benefit of Bet v 1 contiguous overlapping peptide immunotherapy persists during first follow-up season

Benefit of Bet v 1 contiguous overlapping peptide immunotherapy persists during first follow-up season

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Allergy and Clinical Immunology - Volume 142, Issue 2, August 2018, Pages 678-680.e7

Alexander PhD, Gilles MD, Fréderic MD, PhD, Lars PhD, Marek MD, Margitta MD, Vincent PhD, Kim MD, Christophe PhD, François MD,